Entrada Therapeutics, Inc. (5) | License Agreements (2)
- Exclusive License Agreement, by and between the Registrant and OSIF, dated as of December 14, 2018, as amended on October 8, 2019 and further amended on March 9, 2019 (Filed With SEC on October 8, 2021)
- License Agreement (Filed With SEC on October 8, 2021)
